References
- Bardhan KD. Refractory duodenal ulcer. Gut 1984: 25(7): 711–7
- Collen MJ, Stanczak VJ, Ciarleglio CA. Refractory duodenal ulcers (nonhealing duodenal ulcere with standard doses of antisecretory medication). Dig Dis Sci 1989: 34(2): 233–7
- Koop H, Koop I, Klein M, et al. Irradiation-induced duodenal ulcer disease refractory to ranitidine: healing by omeprazole. J Clin Gastroenterol 1989: 11(6): 631–4
- Koop H, Stumpf M, Eisseie R, et al. Antral Helicobacter pylori-like organisms in different states of gastric acid secretion. Digestion 1991: 48(4): 230–6
- Bardhan KD, Naesdal J, Bianchi-Porro G, et al. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial. Gut 1991: 32(4): 435–8
- Arakawa T, Higuchi K, Fukuda T, et al. H2-receptor antagonist-refractory ulcer: its pathophysiology and treatment. J Clin Gastroenterol 1991: 13(Suppl 1): S129–33
- Lancaster-Smith MJ, Jaderberg ME, Jackson DA. Ranitidine in the treatment of nonsteroidal anti-inflammatory drug associated gastric and duodenal ulcers. Gut 1991: 32(3): 252–5
- Jaszewski R, Calzada R, Dhar R. Persistence of gastric ulcers caused by plain aspirin or nonsteroidal antiinflammatory agents in patients treated with a combination of Cimetidine, antacids, and enteric-coated aspirin. Dig Dis Sci 1989: 34(9): 1361–4
- Arakawa T. [H2-receptor antagonist-refractory ulcer: its pathophysiology and role of proton-pump inhibitors.] Nippon Rinsho 1992: 50(1): 122–30 (Jpn, Eng abstr)
- Graham DY, Lew GM, Klein PD, et al. Effect of treatment of Helicobacter pylori infection on the long-term recurrence of gastric or duodenal ulcer: a randomized, controlled study. Ann Intern Med 1992: 116(9): 705–8
- Wagner S, Gebel M, Haruma K, et al. Bismuth subsalicylate in the treatment of H2 blocker resistant duodenal ulcers: role of Helicobacter pylori. Gut 1992: 33(2): 179–83
- McTavish D, Buckley MM, Heel RC. Omeprazole: an updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs 1991: 42(1): 138–70
- Unge P, Olsson J, Gad A, et al. Does omeprazole, 40 mg o.m., improve antimicrobial therapy directed towards gastric Campylobacter pylori in patients with antral gastritis? (Abstr) Scand J Gastroenterol 1989: 24(Suppl 166): 184
- Koop H, Hotz J, Pommer G, et al. Prospective evaluation of omeprazole treatment in reflux oesophagitis refractory to H2-receptor antagonists. Aliment Pharmacol Ther 1990: 4(6): 593–9
- Maton PN. Omeprazole. N Engl J Med 1991: 324(14): 965–75
- Bianchi-Porro G, Pace F, Sangaletti O, et al. High-dose famotidine in the maintenance treatment of refractory esophagitis: results of a “medium-term” open study. Am J Gastroenterol 1991: 86(11): 1585–7
- Vassilakis JS, Xynos E, Mantidis A, et al. Vagotomy for duodenal ulcer resistant to H2-receptor antagonists. Digestion 1989: 44(1): 1–6
- Primrose JN, Axon AT, Johnston D. Highly selective vagotomy and duodenal ulcers that feil to respond to H2 receptor antagonists. BMJ 1988: 296(6628): 1031–5
- Richter JE. Surgery for reflux disease: reflections of a gastroenterologist. N Engl J Med 1992: 326(12): 825–7